The finding that in hepatocellular carcinoma, individuals with a low expression of CB1 and CB2 receptors have a poorer prognosis than individuals with a high expression of these receptors [49] would suggest that a similar mechanism may also be operative in this cancer form. The gene discussed is CNR1; the disease is cancer.